Back
Edwards Lifesciences Quote, Financials, Valuation and Earnings
Sponsored
EW
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
23
EW
Edwards Lifesciences
Last Price:
66.48
Seasonality Move:
7.19%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Edwards Lifesciences Price Quote
$66.48
-1.06 (-1.57%)
(Updated: November 4, 2024 at 5:55 PM ET)
Edwards Lifesciences Key Stats
Sell
23
Edwards Lifesciences (EW)
is a Sell
Day range:
$66.67 - $68.59
52-week range:
$58.93 - $96.12
Dividend yield:
0%
P/E ratio:
29.37
P/S ratio:
6.94
P/B ratio:
5.47%
Volume:
4M
Avg. volume:
6.1M
1-year change:
5.81%
Market cap:
$40.7B
Revenue:
$6B
EPS:
$6.93
How Much Does Edwards Lifesciences Make?
-
How Much Are Edwards Lifesciences's Sales Annually?
EW Revenues are $6B -
How Much Profit Does Edwards Lifesciences's Make A Year?
EW net income is $1.4B
Is Edwards Lifesciences Growing As A Company?
-
What Is Edwards Lifesciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.09% -
What Is Edwards Lifesciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 7.14%
Edwards Lifesciences Stock Price Performance
-
Did Edwards Lifesciences Stock Go Up Last Month?
Edwards Lifesciences share price went up by 3.75% last month -
Did EW's Share Price Rise Over The Last Year?
EW share price rose by 5.81% over the past 1 year
What Is Edwards Lifesciences 52-Week High & Low?
-
What Is Edwards Lifesciences’s 52-Week High Share Price?
Edwards Lifesciences has traded as high as $96.12 over the past 52 weeks -
What Is Edwards Lifesciences’s 52-Week Low Share Price?
Edwards Lifesciences has traded as low as $58.93 over the past 52 weeks
Edwards Lifesciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Edwards Lifesciences?
-
How Much Debt Does Edwards Lifesciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Edwards Lifesciences Have?
Cash and short term investments quarterly total is $2B -
What Is Edwards Lifesciences’s Book Value Per Share?
Book value per share is 12.35
Is Edwards Lifesciences Cash Flow Positive?
-
What Is EW Cash Flow From Operations?
Cash flow from operations (TTM) is $866.1M -
What Is Edwards Lifesciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$591.4M -
What Is Edwards Lifesciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $291M
Edwards Lifesciences Return On Invested Capital
-
Is Management Doing A Good Job?
EW return on invested capital is 54.5% -
What Is Edwards Lifesciences Return On Assets?
ROA measures how assets are converting to revenues and is 43.13% -
What Is EW Return On Equity?
ROE is a measure of profitability and is 21.3%
Edwards Lifesciences Earnings Date & Stock Price
-
What Is Edwards Lifesciences's Stock Price Today?
A single share of EW can be purchased today for 67.54 -
What Is Edwards Lifesciences’s Stock Symbol?
Edwards Lifesciences trades on the S&P500 under the ticker symbol: EW -
When Is Edwards Lifesciences’s Next Earnings Date?
The next quarterly earnings date for Edwards Lifesciences is scheduled on February 6, 2025 -
When Is EW's next ex-dividend date?
Edwards Lifesciences's next ex-dividend date is November 5, 2024 -
How To Buy Edwards Lifesciences Stock?
You can buy Edwards Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Edwards Lifesciences Competitors
-
Who Are Edwards Lifesciences's Competitors?
Below is a list of companies who compete with Edwards Lifesciences or are related in some way:
Edwards Lifesciences Dividend Yield
-
What Is EW Dividend Yield?
Edwards Lifesciences’s dividend yield currently is 0% -
What Is Edwards Lifesciences’s Payout Ratio?
Edwards Lifesciences’s payout ratio is 0% -
When Did Edwards Lifesciences Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Edwards Lifesciences’s Dividend Per Share?
Edwards Lifesciences pays a dividend of $0.00 per share
Edwards Lifesciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 714.29% | 13.97% |
Revenue: | -8.54% | -1.01% |
Analyst Recommendations
Buy Recommendations: | 8 |
---|---|
Hold Recommendations: | 19 |
Sell Recommendations: | 0 |
Price Target: | 76.36 |
Upside from Last Price: | 13.05% |